Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001534899-14-000001
Filing Date
2014-05-06
Accepted
2014-05-06 13:39:30
Documents
1
Effectiveness Date
2014-05-06
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9832
  Complete submission text file 0001534899-14-000001.txt   10854
Mailing Address 128 SPRING ST., STE 620 LEXINGTON MA 02421
Business Address 128 SPRING ST., STE 620 LEXINGTON MA 02421 781-861-0062
AVAXIA BIOLOGICS, Inc (Filer) CIK: 0001534899 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-216859 | Film No.: 14816355